Ralimetinib dimesylate
Product Specifications
CAS Number
862507-23-1
Target
Autophagy, p38 MAPK, Apoptosis
Related Pathways
Apoptosis, Autophagy, MAPK
Purity
0.9938
Bioactivity
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
Smiles
CS(O)(=O)=O.CS(O)(=O)=O.CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C
Molecular Formula
C24H29FN6·2CH4O3S
Molecular Weight
612.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FITC Anti-Mouse CD4 Antibody[GK1.5]](https://cdn.genprice.uk/products/763/68dd14a1061270361e7d07ca/imageurl/e-ab-f1097c.webp)
![CHRM2 Rabbit Monoclonal Antibody [Clone ID: R01-9B9]](https://cdn.genprice.uk/products/937/68dd1b5b061270361ea0fafc/imageurl/ta383998.webp)
TA383998 100 µL
CHRM2 Rabbit Monoclonal Antibody [Clone ID: R01-9B9]
Sign In for Pricing
View Details 
HA601402 100 µL
Synaptopodin Recombinant Chimeric Antibody Antibody
Sign In for Pricing
View Details